Baxter
BAX
#1210
Rank
ยฃ11.91 B
Marketcap
ยฃ23.33
Share price
0.75%
Change (1 day)
-22.86%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2024 (TTM): ยฃ10.92 Billion

According to Baxter's latest financial reports the company's current revenue (TTM ) is ยฃ11.01 Billion. In 2023 the company made a revenue of ยฃ10.75 Billion a decrease over the revenue in the year 2022 that were of ยฃ12.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ10.92 B1.55%
2023 ยฃ10.75 B-12.05%
2022 ยฃ12.23 B29.14%
2021 ยฃ9.47 B10.59%
2020 ยฃ8.56 B-1.16%
2019 ยฃ8.66 B-1.1%
2018 ยฃ8.76 B12.12%
2017 ยฃ7.81 B-5.13%
2016 ยฃ8.23 B22.45%
2015 ยฃ6.72 B-31.03%
2014 ยฃ9.75 B5.86%
2013 ยฃ9.21 B4.93%
2012 ยฃ8.77 B-1.78%
2011 ยฃ8.93 B7.44%
2010 ยฃ8.31 B7.17%
2009 ยฃ7.76 B-7.86%
2008 ยฃ8.42 B48.61%
2007 ยฃ5.66 B7.01%
2006 ยฃ5.29 B-7.23%
2005 ยฃ5.71 B15.31%
2004 ยฃ4.95 B-0.61%
2003 ยฃ4.98 B-0.55%
2002 ยฃ5.01 B-5.18%
2001 ยฃ5.28 B14.39%
2000 ยฃ4.62 B17.02%
1999 ยฃ3.94 B6.76%
1998 ยฃ3.69 B-1.02%
1997 ยฃ3.73 B17.65%
1996 ยฃ3.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ176.60 B 1,503.81%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.29 B 57.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.52 B 13.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.88 B 44.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.74 B-93.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ33.35 B 202.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.23 B-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.39 B-23.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.97 B 135.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ1.84 B-83.27%๐Ÿ‡บ๐Ÿ‡ธ USA